TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE:MLZ) (”MediPharm” or the ”Company”), a pharmaceutical c
MediPharm Labs (TSX: LABS) warns shareholders against voting for three of Apollo's director nominees due to poor governance history at Check-Cap Ltd. Ch
TORONTO, May 23, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (”MediPharm”, the ”Company”, or ”we”), a pharmaceutical company special
TORONTO, May 22, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-b
TORONTO, May 21, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-b
PR NewswireTORONTO, May 15, 2025
TORONTO, May 15, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical com
PR NewswireTORONTO, May 14, 2025
Company Has Suspended Calls Since the Second Quarter of 2024 to Avoid Facing the Music for Board's and Management Team's D
PR NewswireTORONTO, May 14, 2025
Achieves Positive Adjusted EBITDA(1)Revenue of $10.8 Million, an Increase of 11% over Q1 202487% Growth in International M
MediPharm Labs (MEDIF) to announce Q1 2025 financial results on May 14, 2025. A conference call and webcast will be held at 10:00 a.m. Eastern time on t
PR NewswireTORONTO, May 8, 2025
TORONTO, May 8, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical compa